Windtree Therapeutics (WINT) Stock Price, Quote, News & History

Windtree Therapeutics Inc (WINT) Stock Price, Quote, News & History

WINTOTCID

Trade with Public

$0.1100

At close: Aug 29, 5:00 PM EST

Key Statistics

Open

Volume / Avg.

200.34K / 340.11K

Day Range

- - -

52 Wk Range

0.01 - 3.48

Market Cap

$337.09K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Windtree Therapeutics Inc News

Why Are Public Companies Amassing ETH, XRP, SOL, BNB Instead Of Just Bitcoin?

Publicly traded companies are increasingly integrating cryptocurrencies other than Bitcoin (CRYPTO: BTC), into their treasuries, with significant investments announced in Ethereum (CRYPTO: ETH), Solana (CRYPTO:

Murtuza J Merchant

Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings

Avi Kapoor

Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.12M

Investing Cash Flow (TTM)

-5.97M

Financing Cash Flow (TTM)

19.00M

Free Cash Flow (TTM)

-15.12M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.10M

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$13.18M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

2393185.19%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.34

Company Debt

Total Debt

$12.14M

LT Debt

LT Debt Issuance (TTM)

$1.31M

LT Debt Repayment (TTM)

-$2.00M

Total Cash

$204.00K

Debt to Equity

Issuance of Debt (TTM)

-$688.00K

Repayment of Debt (TTM)

-$3.12M

Key Statistics

Open

Volume / Avg.

200.34K / 340.11K

Day Range

- - -

52 Wk Range

0.01 - 3.48

Market Cap

$337.09K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticul...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Windtree Therapeutics (WINT) stock?

You can purchase shares of Windtree Therapeutics (OTCID:WINT) through any online brokerage.

View our list of the best stock brokerages

Who are Windtree Therapeutics (WINT) competitors?

There are no as such competitors for Windtree Therapeutics.

What is the forecast, or price target, for Windtree Therapeutics (WINT) stock?

Windtree Therapeutics has a consensus price target of $7.00.

What is the current price for Windtree Therapeutics (WINT)?

The stock price for Windtree Therapeutics (OTCID: WINT) is $0.01 last updated March 9, 2026 at 11:50 AM EDT.

Does Windtree Therapeutics (WINT) pay a dividend?

There are no upcoming dividends for Windtree Therapeutics.

When is Windtree Therapeutics (OTCID:WINT) reporting earnings?

Windtree Therapeutics does not have any upcoming earnings scheduled.

Is Windtree Therapeutics (WINT) going to split?

There is no upcoming split for Windtree Therapeutics.

What sector and industry does Windtree Therapeutics (WINT) operate in?

Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCID.

Key Statistics

Open

Volume / Avg.

200.34K / 340.11K

Day Range

- - -

52 Wk Range

0.01 - 3.48

Market Cap

$337.09K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Windtree Therapeutics Inc News

Why Are Public Companies Amassing ETH, XRP, SOL, BNB Instead Of Just Bitcoin?

Murtuza J Merchant

Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings

Avi Kapoor

Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.12M

Investing Cash Flow (TTM)

-5.97M

Financing Cash Flow (TTM)

19.00M

Free Cash Flow (TTM)

-15.12M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.10M

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$13.18M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

2393185.19%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.34

Company Debt

Total Debt

$12.14M

LT Debt

LT Debt Issuance (TTM)

$1.31M

LT Debt Repayment (TTM)

-$2.00M

Total Cash

$204.00K

Debt to Equity

Issuance of Debt (TTM)

-$688.00K

Repayment of Debt (TTM)

-$3.12M

Key Statistics

Open

Volume / Avg.

200.34K / 340.11K

Day Range

- - -

52 Wk Range

0.01 - 3.48

Market Cap

$337.09K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Windtree Therapeutics (WINT) stock?

You can purchase shares of Windtree Therapeutics (OTCID:WINT) through any online brokerage.

View our list of the best stock brokerages

Who are Windtree Therapeutics (WINT) competitors?

There are no as such competitors for Windtree Therapeutics.

What is the forecast, or price target, for Windtree Therapeutics (WINT) stock?

Windtree Therapeutics has a consensus price target of $7.00.

What is the current price for Windtree Therapeutics (WINT)?

The stock price for Windtree Therapeutics (OTCID: WINT) is $0.01 last updated March 9, 2026 at 11:50 AM EDT.

Does Windtree Therapeutics (WINT) pay a dividend?

There are no upcoming dividends for Windtree Therapeutics.

When is Windtree Therapeutics (OTCID:WINT) reporting earnings?

Windtree Therapeutics does not have any upcoming earnings scheduled.

Is Windtree Therapeutics (WINT) going to split?

There is no upcoming split for Windtree Therapeutics.

What sector and industry does Windtree Therapeutics (WINT) operate in?

Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCID.